No record found
No record found
capitalstake.com. Provided by * Returns not adjusted for payouts
^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.
Company Profile
AGP Limited was incorporated as a public limited company in May 2014 under the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company got listed on Pakistan Stock Exchange Limited on 05 March 2018. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale and manufacturing of all kinds of pharmaceutical products. Aitkenstuart Pakistan (Private) Limited (parent company) holds 55.80% of the share capital of the Company and West End 16 Pte Limited, Singapore is the ultimate parent company.
| Muhammad Kamran Nasir | CEO |
| Tariq Moinuddin Khan | Chairperson |
| Muhammad Asad Khan | Company Secretary |
CDC Share Registrar Services Limited
Grant Thornton Anjum Rehman Chartered Accountants
December
Equity Profile
Announcements
| Date | Title | Document |
|---|---|---|
| Apr 30, 2026 | Transmission of Quarterly Report for the Period Ended March 31, 2026 | View PDF |
| Apr 30, 2026 | Financial Results for the Quarter Ended 2026-03-31 | View PDF |
| Mar 30, 2026 | Transmission of Annual Report for the Year Ended December 31, 2025 | View PDF |
| Mar 24, 2026 | Financial Results for the Year Ended December 31, 2025 | View PDF |
| Oct 30, 2025 | Transmission of Quarterly Report for the Period Ended September 30, 2025 | View PDF |
| Date | Title | Document |
|---|---|---|
| Apr 29, 2026 | Board Meeting in Progress | View PDF |
| Apr 22, 2026 | Board Meeting | View PDF |
| Apr 20, 2026 | Abstract of Resolutions Passed in 12th Annual General Meeting | View PDF |
| Mar 30, 2026 | Notice of 12th Annual General Meeting For The Year December 31, 2025 | View PDF |
| Mar 19, 2026 | Board Meeting In Progress | View PDF |
Financials
All numbers in thousands (000's) except EPS
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 20,545,689 | 18,543,808 | 13,857,770 | 10,262,015 |
| Profit after Taxation | 2,360,314 | 2,083,581 | 1,190,186 | 1,428,034 |
| EPS | 8.43 | 7.44 | 4.25 | 5.10 |
| Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|
| Sales | 5,386,574 | 5,586,805 | 4,270,363 | 4,814,159 |
| Profit after Taxation | 556,924 | 671,271 | 626,927 | 465,700 |
| EPS | 1.99 | 2.40 | 2.24 | 1.66 |

Ratios
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Gross Profit Margin (%) | 48.62 | 47.84 | 44.32 | 50.89 |
| Net Profit Margin (%) | 11.49 | 11.24 | 8.59 | 13.92 |
| EPS Growth (%) | 13.31 | 75.06 | (16.67) | (8.77) |
| PEG | 1.81 | 0.30 | (0.99) | (1.45) |









Feedback
Terms of Use
https://www.psx.com.pk